SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-022188
Filing Date
2019-08-21
Accepted
2019-08-21 06:05:29
Documents
2
Period of Report
2019-08-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1574
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4721
  Complete submission text file 0000899243-19-022188.txt   7663
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address
TOMBESI PAOLO (Reporting) CIK: 0001707648 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35945 | Film No.: 191041192